VSL#3 is a high-potency probiotic mixture that contains three strains of bifidobacteria, four strains of lactobacilli and Streptococcus thermophilus. VSL#3 has undergone the highest standards of scrutiny available for natural health products.
A 2014 meta-analysis of the effect of VSL#3 on inducing remission and maintaining therapy in UC and pouchitis concluded:
“Administration of probiotics results in additional benefit in inducing remission of patients with UC. VSL#3 are beneficial for maintaining remission in patients with pouchitis. And, probiotics can provide [an effect similar to] 5-aminosalicylic acid on maintaining remission of UC, although no additional adverse events presented.”
SIMILAR RESULTS WERE OBSERVED IN OTHER CLINICAL TRIALS, WHICH CONCLUDED:
“ . . . VSL#3 may be considered as a safe and effective option for patients suffering from relapsing mild-to-moderate UC, to avoid or delay the administration of steroids, immunosuppressants, and biologics.”